Emergency Department, Central Clinical Hospital of the Ministry of the Interior and Administration in Warsaw, 137 Wołoska St., 02-004 Warsaw, Poland.
Clinical Department of Neurosurgery, Central Clinical Hospital of the Ministry of the Interior and Administration in Warsaw, 137 Wołoska St., 02-004 Warsaw, Poland.
Int J Environ Res Public Health. 2022 Mar 25;19(7):3932. doi: 10.3390/ijerph19073932.
The outbreak of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic has affected all aspects of social life and brought massive changes to the healthcare sector. The aim of this study was to identify the factors affecting the mortality of COVID-19 patients at a temporary hospital in Warsaw (Poland). The present study was conducted based on a retrospective analysis of the medical records of patients hospitalised at the temporary hospital located at the National Stadium in Warsaw between 1 March 2020 and 30 April 2021. The study included all cases of patients who were brought directly or transferred to the National Hospital from other hospitals for further treatment. With regard to comorbidities, the analysis found that five comorbidities—namely, diabetes (OR = 1.750, 95% CI: 1.009−2.444, p < 0.05), stroke history (OR = 2.408, 95% CI: 1.208−4.801, p < 0.05), renal failure (OR = 2.141, 95% CI: 1.052−4.356, p < 0.05), chronic obstructive pulmonary disease (OR = 2.044, 95% CI: 1.133−3.690, p < 0.05) and heart failure (OR = 1.930, 95% CI: 1.154−3.227, p < 0.05)—had a significant impact on the survival of COVID-19 patients. The analysis identified 14 factors that had a significant impact on the prognosis and mortality of the COVID-19 patients studied.
新冠病毒(SARS-CoV-2,严重急性呼吸综合征冠状病毒 2)疫情的爆发对社会生活的各个方面都产生了影响,并给医疗保健领域带来了巨大变化。本研究旨在确定影响华沙(波兰)临时医院 COVID-19 患者死亡率的因素。本研究基于对 2020 年 3 月 1 日至 2021 年 4 月 30 日期间位于华沙国家体育场的临时医院住院患者病历的回顾性分析。本研究包括所有直接或从其他医院转至国立医院进行进一步治疗的患者病例。就合并症而言,分析发现五种合并症,即糖尿病(OR = 1.750,95%CI:1.009−2.444,p < 0.05)、中风病史(OR = 2.408,95%CI:1.208−4.801,p < 0.05)、肾衰竭(OR = 2.141,95%CI:1.052−4.356,p < 0.05)、慢性阻塞性肺疾病(OR = 2.044,95%CI:1.133−3.690,p < 0.05)和心力衰竭(OR = 1.930,95%CI:1.154−3.227,p < 0.05)对 COVID-19 患者的生存有显著影响。分析确定了 14 个对研究中 COVID-19 患者预后和死亡率有显著影响的因素。